These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10555186)

  • 1. Anticardiolipin antibodies are an independent risk factor for ischemic stroke.
    Zieliñska J; Ryglewicz D; Wierzchowska E; Lechowicz W; Hier DB; Czlonkowska A
    Neurol Res; 1999 Oct; 21(7):653-7. PubMed ID: 10555186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis.
    Ginsburg KS; Liang MH; Newcomer L; Goldhaber SZ; Schur PH; Hennekens CH; Stampfer MJ
    Ann Intern Med; 1992 Dec; 117(12):997-1002. PubMed ID: 1443986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and Västerbotten cohort project.
    Ahmed E; Stegmayr B; Trifunovic J; Weinehall L; Hallmans G; Lefvert AK
    Stroke; 2000 Jun; 31(6):1289-93. PubMed ID: 10835446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of persistent anticardiolipin antibody as risk factor of ischemic stroke.
    Immanuel S; Giantini A; Dharma RS; Samino
    Acta Med Indones; 2005; 37(4):205-9. PubMed ID: 16354941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High titer of anticardiolipin antibody is associated with first-ever ischemic stroke in Taiwan.
    Lien LM; Chen WH; Chiu HC; Pan WH; Chen JR; Bai CH
    Cerebrovasc Dis; 2006; 22(4):225-30. PubMed ID: 16788294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.
    Urbanus RT; Siegerink B; Roest M; Rosendaal FR; de Groot PG; Algra A
    Lancet Neurol; 2009 Nov; 8(11):998-1005. PubMed ID: 19783216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of anticardiolipin antibodies in patients with asymptomatic hepatitis C virus infection associated acute ischemic stroke.
    Cojocaru IM; Cojocaru M; Iacob SA
    Rom J Intern Med; 2005; 43(1-2):89-95. PubMed ID: 16739869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study.
    Janardhan V; Wolf PA; Kase CS; Massaro JM; D'Agostino RB; Franzblau C; Wilson PW
    Stroke; 2004 Mar; 35(3):736-41. PubMed ID: 14764933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. The Antiphospholipid Antibodies in Stroke Study (APASS) Group.
    Neurology; 1993 Oct; 43(10):2069-73. PubMed ID: 8413969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity.
    Tuhrim S; Rand JH; Wu XX; Weinberger J; Horowitz DR; Goldman ME; Godbold JH
    Stroke; 1999 Aug; 30(8):1561-5. PubMed ID: 10436101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticardiolipin antibodies in acute non-hemorrhagic stroke seen within six hours after onset.
    Camerlingo M; Casto L; Censori B; Drago G; Frigeni A; Ferraro B; Servalli MC; Radice E; Mamoli A
    Acta Neurol Scand; 1995 Jul; 92(1):69-71. PubMed ID: 7572064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which risk factors are more associated with ischemic stroke than intracerebral hemorrhage in patients with atrial fibrillation?
    McGrath ER; Kapral MK; Fang J; Eikelboom JW; ó Conghaile A; Canavan M; O'Donnell MJ;
    Stroke; 2012 Aug; 43(8):2048-54. PubMed ID: 22618379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of immunologic testing in stroke patients. A prospective multicenter study.
    Montalbán J; Rio J; Khamastha M; Davalos A; Codina M; Swana GT; Calcagnotto ME; Sumalla J; Mederer S; Gil A
    Stroke; 1994 Dec; 25(12):2412-5. PubMed ID: 7974582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticardiolipin antibodies as an independent risk factor for stroke in young Saudis.
    Daif AK
    Funct Neurol; 1998; 13(4):285-9. PubMed ID: 9934572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticardiolipin antibodies and mortality in patients with ischemic stroke: a prospective follow-up study.
    Tanne D; D'Olhaberriague L; Trivedi AM; Salowich-Palm L; Schultz LR; Levine SR
    Neuroepidemiology; 2002; 21(2):93-9. PubMed ID: 11901279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticardiolipin antibodies in ischemic stroke in the young: Indian experience.
    Nagaraja D; Christopher R; Manjari T
    J Neurol Sci; 1997 Sep; 150(2):137-42. PubMed ID: 9268241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children.
    Lanthier S; Kirkham FJ; Mitchell LG; Laxer RM; Atenafu E; Male C; Prengler M; Domi T; Chan AK; Liesner R; deVeber G
    Neurology; 2004 Jan; 62(2):194-200. PubMed ID: 14745053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHA
    Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of periprocedural neurological deficit in carotid stenting with increased anticardiolipin antibodies.
    Steiner S; Sadushi R; Bartok A; Hammer A; Quehenberger P; Mannhalter C; Koppensteiner R; Minar E; Kopp CW
    Thromb Res; 2009 Apr; 123(6):827-31. PubMed ID: 18817951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to beta(2)-glycoprotein I in ischemic stroke.
    Fiallo P; Tomasina C; Clapasson A; Cardo PP
    Cerebrovasc Dis; 2000; 10(4):293-7. PubMed ID: 10878435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.